dc.contributor.author | Través, Paqui G | |
dc.contributor.author | Luque, Alfonso | |
dc.contributor.author | Hortelano, Sonsoles | |
dc.date.accessioned | 2021-04-29T10:48:13Z | |
dc.date.available | 2021-04-29T10:48:13Z | |
dc.date.issued | 2012-10-17 | |
dc.identifier.citation | Oncoimmunology. 2012;1(6): 946-947 | es_ES |
dc.identifier.issn | 2162-4011 | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/12823 | |
dc.description.abstract | ARF (alternative reading frame) is one of the most important tumor regulator playing critical roles in controlling tumor initiation and progression. Recently, we have demonstrated a novel and unexpected role for ARF as modulator of inflammatory responses. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Taylor & Francis | es_ES |
dc.relation.isversionof | Publisher's version | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc/4.0/ | * |
dc.subject | Cancer | es_ES |
dc.subject | Inflammation | es_ES |
dc.subject | Macrophages | es_ES |
dc.subject | p19ARF | es_ES |
dc.subject | Tumor suppressor | es_ES |
dc.title | Tumor suppressor ARF: The new player of innate immunity. | es_ES |
dc.type | Artículo | es_ES |
dc.rights.license | Atribución-NoComercial 4.0 Internacional | * |
dc.identifier.pubmedID | 23162766 | es_ES |
dc.format.volume | 1 | es_ES |
dc.format.number | 6 | es_ES |
dc.format.page | 946-947 | es_ES |
dc.identifier.doi | 10.4161/onci.19948 | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.relation.publisherversion | https://doi.org/10.4161/onci.19948 | es_ES |
dc.identifier.journal | Oncoimmunology | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es_ES |